The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis I. Study rationale and design
暂无分享,去创建一个
R. Hoffman | T. McGlashan | M. Tohen | S. Woods | S. Lindborg | D. Perkins | K. Hawkins | J. Addington | R. Zipursky | A. Breier | M Tohen | A Breier | T. Miller | J Addington | D Perkins | T. H McGlashan | R. B Zipursky | T. J Miller | S. W Woods | K. A Hawkins | R Hoffman | S Lindborg | J. Addington | R. Hoffman | D. Perkins | S. Woods
[1] S. Kay,et al. The positive and negative syndrome scale (PANSS) for schizophrenia. , 1987, Schizophrenia bulletin.
[2] A. Yung,et al. The Initial Prodrome in Psychosis: Descriptive and Qualitative Aspects , 1996, The Australian and New Zealand journal of psychiatry.
[3] Adrian Preda,et al. Treatment histories of patients with a syndrome putatively prodromal to schizophrenia. , 2002, Psychiatric services.
[4] G. Simpson,et al. A RATING SCALE FOR EXTRAPYRAMIDAL SIDE EFFECTS , 1970, Acta psychiatrica Scandinavica. Supplementum.
[5] I. Falloon,et al. Early intervention for first episodes of schizophrenia: a preliminary exploration. , 1992, Psychiatry.
[6] S. Strakowski,et al. Attention deficit hyperactivity disorder in adolescent mania. , 1995, The American journal of psychiatry.
[7] T. McGlashan,et al. Early detection and intervention in schizophrenia: editor's introduction. , 1996, Schizophrenia bulletin.
[8] T. McGlashan,et al. Prospective diagnosis of the initial prodrome for schizophrenia based on the Structured Interview for Prodromal Syndromes: preliminary evidence of interrater reliability and predictive validity. , 2002, The American journal of psychiatry.
[9] Predicting schizophrenia in teenagers: Pessimistic results from the British 1946 birth cohort , 1998, Schizophrenia Research.
[10] L. J. Chapman,et al. Putatively psychosis-prone subjects 10 years later. , 1994, Journal of abnormal psychology.
[11] Martin Hellmich,et al. Diagnosing Schizophrenia in the Initial Prodromal Phase , 2001 .
[12] R. Tamura,et al. Randomised double-blind comparison of the incidence of tardive dyskinesia in patients with schizophrenia during long-term treatment with olanzapine or haloperidol , 1999, British Journal of Psychiatry.
[13] J. Lieberman,et al. Olanzapine Versus Haloperidol Treatment in First-Episode Psychosis , 1999 .
[14] W. Coryell,et al. The reliability of the family history method for psychiatric diagnoses. , 1988, Archives of general psychiatry.
[15] J. O. Johannessen,et al. Shortened duration of untreated first episode of psychosis: changes in patient characteristics at treatment. , 2001, The American journal of psychiatry.
[16] H. Häfner,et al. Epidemiology of Schizophrenia , 1997, Canadian journal of psychiatry. Revue canadienne de psychiatrie.
[17] T. McGlashan,et al. Early detection and intervention in schizophrenia: research. , 1996, Schizophrenia bulletin.
[18] D. Linszen,et al. Early detection and intervention in schizophrenia , 1998, International clinical psychopharmacology.
[19] G. Patton,et al. Prediction of psychosis , 1998, British Journal of Psychiatry.
[20] H. Häfner,et al. The Prodromal Phase of Psychosis , 2001 .
[21] W. Dryden,et al. Problem-Solving Therapy , 1988, Journal of Cognitive Psychotherapy.
[22] C. Beasley,et al. Olanzapine versus haloperidol: acute phase results of the international double-blind olanzapine trial , 1997, European Neuropsychopharmacology.
[23] Charles M Beasley,et al. Olanzapine versus Placebo and Haloperidol , 1996, Neuropsychopharmacology.
[24] M. Alda,et al. Study of chronic schizophrenics with positive and negative family histories of psychosis , 1991, Acta psychiatrica Scandinavica.
[25] T. McGlashan. Treating schizophrenia earlier in life and the potential for prevention , 2003, Current psychiatry reports.
[26] G C Patton,et al. Monitoring and care of young people at incipient risk of psychosis. , 1996, Schizophrenia bulletin.
[27] J. O. Johannessen,et al. Early intervention in psychotic disorders , 2001 .
[28] T. Barnes. A Rating Scale for Drug-Induced Akathisia , 1989, British Journal of Psychiatry.
[29] T. McGlashan,et al. Gender differences in affective, schizoaffective, and schizophrenic disorders A review , 1990, Schizophrenia Research.
[30] R. Tamura,et al. Blind, controlled, long-term study of the comparative incidence of treatment-emergent tardive dyskinesia with olanzapine or haloperidol. , 1997 .
[31] R. C. Young,et al. A Rating Scale for Mania: Reliability, Validity and Sensitivity , 1978, British Journal of Psychiatry.
[32] R. Hoffman,et al. Symptom Assessment in Schizophrenic Prodromal States , 2004, Psychiatric Quarterly.
[33] R. Wyatt,et al. Measurement of premorbid adjustment in chronic schizophrenia. , 1982, Schizophrenia bulletin.
[34] G. Gross. The ‘Basic’ Symptoms of Schizophrenia , 1989, British Journal of Psychiatry.
[35] A Reichenberg,et al. Behavioral and intellectual markers for schizophrenia in apparently healthy male adolescents. , 1999, The American journal of psychiatry.
[36] T. McGlashan. Duration of untreated psychosis in first-episode schizophrenia: marker or determinant of course? , 1999, Biological Psychiatry.
[37] M. Goldfried,et al. Problem solving and behavior modification. , 1971, Journal of abnormal psychology.
[38] H. S. Sullivan. THE ONSET OF SCHIZOPHRENIA , 1927 .
[39] J. Lieberman,et al. Delayed detection of psychosis: causes, consequences, and effect on public health. , 2000, The American journal of psychiatry.
[40] H. Häfner,et al. Methodological aspects of onset assessment in schizophrenia , 1995, Schizophrenia Research.
[41] F. Baker,et al. Quality of life in the evaluation of community support systems. , 1982, Evaluation and program planning.
[42] R. C. Hall,et al. Global assessment of functioning. A modified scale. , 1995, Psychosomatics.
[43] N C Andreasen,et al. The Comprehensive Assessment of Symptoms and History (CASH). An instrument for assessing diagnosis and psychopathology. , 1992, Archives of general psychiatry.
[44] A. Riecher-Rössler,et al. First onset and early symptomatology of schizophrenia , 1992, European Archives of Psychiatry and Clinical Neuroscience.
[45] T. McGlashan. Psychosis treatment prior to psychosis onset: ethical issues , 2001, Schizophrenia Research.
[46] T. McGlashan,et al. Diagnosis and symptom assessment in the schizophrenia prodrome , 2003, Schizophrenia Research.
[47] D. Jeste,et al. Lower Incidence of Tardive Dyskinesia with Risperidone Compared with Haloperidol in Older Patients , 1999, Journal of the American Geriatrics Society.
[48] A. Loranger. Sex difference in age at onset of schizophrenia. , 1984, Archives of general psychiatry.
[49] R. Tamura,et al. Olanzapine versus haloperidol in the treatment of schizophrenia and schizoaffective and schizophreniform disorders: results of an international collaborative trial. , 1997, The American journal of psychiatry.
[50] E. Sacchetti,et al. H2 antagonist nizatidine may control olanzapine-associated weight gain in schizophrenic patients , 2000, Biological Psychiatry.
[51] P. Møller,et al. The initial prodrome in schizophrenia: searching for naturalistic core dimensions of experience and behavior. , 2000, Schizophrenia bulletin.
[52] M. Åsberg,et al. A New Depression Scale Designed to be Sensitive to Change , 1979, British Journal of Psychiatry.
[53] W. Glazer,et al. Expected incidence of tardive dyskinesia associated with atypical antipsychotics. , 2000, The Journal of clinical psychiatry.
[54] L. J. Chapman,et al. The search for symptoms predictive of schizophrenia. , 1987, Schizophrenia bulletin.
[55] T. McGlashan,et al. Pre-onset detection and intervention research in schizophrenia psychoses: current estimates of benefit and risk. , 2001, Schizophrenia bulletin.